Events Archive

Opportunities to Expand Equitable Access to HIV Prevention Services through Community Pharmacies

RxEACH is a national coalition effort working to expand and sustain access to HIV prevention and linkage to care services in community pharmacies. Community pharmacies are poised to unlock access to HIV prevention services, particularly in areas where it is most needed, and can play a crucial role in achieving equitable PrEP access. With over…

Online pharmacy PrEP and PEP: Evidence, learnings, and recommendations from Kenya

Click here to access the recording. Private and community pharmacies, coupled with online pharmacy/telehealth platforms, hold promise as convenient pathways to enhance access and effective use of post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP). To generate evidence on the feasibility and effectiveness of an online pharmacy to support PrEP and PEP initiation, continuation, and PEP-to-PrEP…

Where’s the Equity? Including People with Disabilities in HIV Prevention Programming and Research

Recording / Slides / Resources As a movement motivated by health and human rights, the HIV field has collectively been tuning in more than ever to the importance of diversity, equity and inclusion when it comes to HIV prevention programming and research. That said, there seems to be less awareness and effort around the inclusion…

Welcome to the Era of PrEP Choice

This event will be held in Munich, Germany, and virtually (open to AIDS 2024 conference registrants) Are you attending the International AIDS Conference (AIDS 2024) in Munich, Germany, or online? Join us for a pre-conference event hosted by USAID, Unitaid, the Bill & Melinda Gates Foundation, and the World Health Organization with organizational support from…

You Get What You Measure: Why Monitoring for PrEP Choice Helps Tell Our Story

English recording / French audio recording / Portuguese audio recording / Webinar slides / Strengthening and harmonising PrEP indicators The data we collect on a program determines its path and priorities. This webinar will cover the current state of PrEP M&E and efforts to improve and simplify the data we collect, allowing our data to…

Leading the Way: Early learnings from CAB for PrEP introduction in Zambia and Zimbabwe

Slides / Recording Programmatic rollout of long-acting injectable cabotegravir (CAB for PrEP) has launched in Zambia and Zimbabwe! Recommended by the World Health Organization as a safe and effective HIV prevention method in 2022, these two countries are now the first in Africa to incorporate this new, long-awaited PrEP product into their national HIV prevention…

PrEP and the Role of HIV Self-testing

Recording / Slides HIV self-testing (HIVST) is a safe, accurate, and effective alternative to provider-administered testing that many users prefer for its convenience and confidentiality. At IAS 2023, WHO issued a new recommendation to offer HIVST for PrEP initiation and continuation as an innovative way to increase PrEP access and coverage and further simplify PrEP…

We Can’t End HIV in the United States Without Equitable PrEP Access: Strategies for success

A collaboration between HIVMA, PrEP4All, and The Choice Agenda, this webinar will assess some of the key challenges to delivering PrEP in the United States equitably, including cost, the complexities of our health care system, and other factors that inhibit uptake amongst the most vulnerable communities. Strategies to address these challenges will be offered, with…

Discussing Early Results from the SEARCH Dynamic Choice Study

Watch the recording. Join AVAC and Professor Moses Kamya of Makerere University to find out why the early results of the SEARCH Dynamic Choice study were some of the most exciting to come out of CROI in 2024. Conducted in Kenya and Uganda, the study offered oral PrEP, PEP or injectable cabotegravir to both men…

The More We Know: Evolving our understanding of PrEP for cisgender women

Recording / Ukrainian Audio / Slides / Resources / English Transcript / Ukrainian Transcript Science and real-world experience continue to demand a re-assessment of our collective understanding of the safety and effectiveness of PrEP options for women, including oral, vaginal ring, and injectable options. For instance, a new paper in the Journal of the American…